Result : 33

Screening for cancer in case of venous thromboembolism: when and how ?

Cancer associated thrombosis (CAT) is an important challenge. When venous thromboembolism (VTE) occurs without any identified risk factors, the risk of CAT raises the question of a hidden cancer...
 Marie-Antoinette Sevestre. May 2022, page 14

Hypercoagulability in cancer

Gilles Pernod. May 2022, page 18

Treatment of cancer associated thrombosis

The treatment of cancer-associated venous thromboembolic disease is complex due to an increased risk of thrombotic recurrence and bleeding under treatment. During the first 6 months, low molecular...
 Olivier Sanchez. May 2022, page 21

Catheter thrombosis and upper extremity thrombosis in oncology

In an oncologic population with catheter, upper extremity vein thrombosis (UEVT) is a frequent complication, occurring in 2% to 6% of cancer patients with central venous catheters. UEVT is less...
 Olivier Espitia. May 2022, page 26

Venous thromboembolic disease and cancer: 10 key messages

 Karine Lacombe. May 2022, page 36

Epidemiology, risk factors and current screening in rectal cancer

Incidence and survival data from the Francim Cancer Registry Network allowed an estimate of the national incidence of rectal cancer and its prognosis up to 20 years after diagnosis. In 2018, 13 744...
 Anne-Marie Bouvier, Sylvain Manfredi. March 2022, page 18

Initial staging of rectal cancer

Rectal cancers are one of the most frequent digestive cancers. Most of them are diagnosed during organized cancer screening or based on evocative symptoms. After a thorough clinical examination...
 Ingrid Faouzi, Olivier Lucidarme. March 2022, page 25

Contribution of neoadjuvant chemotherapy in rectal cancer

In patients with locally advanced rectal cancer, preoperative radiotherapy and complete mesorectal excision have reduced the risk of locoregional recurrence. However, these treatments have not...
 Jean-Baptiste Bachet. March 2022, page 31

Rectal cancer: Is the era for de-escalation arrived ?

The reference treatment of rectal cancer relies on carcinologic resection including total mesorectal excision. In patients with locally advanced rectal cancer (cT3T4 and/or cN+), preoperative...
 Antoine Brouquet. March 2022, page 39

Rectal cancers resected for cure: monitoring, secondary prevention and late complications

Colorectal cancer incidence has increased by more than 50 % over the past 30 years. Over the same period, the number of deaths has remained stable, reflecting major therapeutic advances. The 5-year...
 Côme Lepage. March 2022, page 44

Rectal cancer: 10 key messages

 Jean-Baptiste Bachet. March 2022, page 51

Epidemiology, classification and risk factors of endometrial cancer

 Claire Sanson. December 2022, page 27

Microsatellite instability in endometrial cancer

The microsatellite instability reflects genetic instability that can be sought in tumors, using two methods, immunohistochemistry and molecular biology. Currently in France, a systematic evaluation...
 Justine Varinot. December 2022, page 30

Evolution of endometrial cancer surgery

Minimally invasive surgery (laparoscopic or robotic assisted) is currently recommended when surgery is envisaged, including for patients in the high risk group. The place of the uterine manipulator...
 Geoffroy Canlorbe, Marianne Nikpayam, Jérémie Belghiti. December 2022, page 35

Adjuvant treatments for endometrial cancer

Primary treatment for endometrial carcinoma is surgical. Adjuvant treatment is based on risk profile according to histological type, grade, lymphovascular involvement, FIGO stage and genomic...
 Nicolas Meillan. December 2022, page 41

Conservative treatments for endometrial cancer

Treatment for early endometrial cancer remains based on hysterectomy. However, in patients of reproductive age with a pregnancy desire, conservative alternative may be considered in case of...
 Maha Eid, Clémentine Gonthier, Margot Bucau, Martin Koskas. December 2022, page 45

News in endometrial cancers: 10 key messages

 Catherine Uzan. December 2022, page 49

Risk and protective factors for colorectal cancer

Behaviour and environment play a more important role than heredity in colorectal carcinogenesis. The proportion of colorectal cancers (CRCs) attributable to occupational exposure, pollution or poor...
 Bernard Denis. December 2022, page 63

Epidemiology and risk factors of cancers of the upper aero-digestive tract

With more than 18.000 cases annually, head and neck cancers rank 5th among the most common cancers in France. In 90% of cases, it is squamous cell carcinoma. It reaches the oral cavity in 25%, 15%...
 Nicolas Le Clerc. March 2023, page 18

HPV vaccination and prevention of oropharyngeal cancers

Anti-HPV vaccination was proposed in France from 2006 to prevent anogenital cancers, and in particular cancer of the cervix. This vaccination was mainly offered to young girls. However, HPV-induced...
 Erwan de Mones Del Pujol. March 2023, page 21

Imaging assessment and diagnostic guidance of upper aerodigestive tract cancers

The upper aerodigestive tract (UADT) has a complex anatomical architecture, which is only partially accessible by clinical examination and for which a detailed imaging analysis is necessary to...
 Anne-Laure Gaultier, Guillaume Reverdito, Aurélien Saltel-Fulero. March 2023, page 24

Therapeutic strategies for upper aerodigestive tract cancers

Upper aerodigestive tract squamous cell carcinomas are the most frequent head and neck cancers. They are generally associated with alcohol and tobacco, but can also be HPV-induced for the...
 Julia Fanchette, Caroline Halimi. March 2023, page 31

Is surgery for ENT cancers less mutilating than in the past ?

 Nicolas Le Clerc. March 2023, page 38

Surveillance after cancer of the upper aerodigestive tract

 Gérald Bonardel, Nicolas Le Clerc. March 2023, page 40

Cancers of the upper aerodigestive tract: the particular case of nasopharyngeal cancer

Nasopharyngeal carcinomas belong –in France- to the spectrum of rare diseases with several specificities owing to their etiology, epidemiology, diagnosis and therapeutics compared with other head...
 François-Régis Ferrand, Pierre Busson. March 2023, page 45

Cancers of the upper aerodigestive tract: 10 key messages

 Nicolas Le Clerc. March 2023, page 52

Therapeutic advances in HER2+ breast cancer

58,000 new cases of breast cancer occured in France in 2018, of which 15-20% are HER2-positive. HER2-targeted therapies deeply modified the management of these tumors, first by the introduction of...
 Marie Alexandre, William Jacot. June 2023, page 33

Cancer and fertility preservation

The integration of fertility preservation into the treatment pathway is a major issue for quality of life after cancer, particularly for very young children, adolescents and young adults. Responses...
 Blandine Courbiere, Catherine Poirot, Christine Decanter, Nathalie Rives, Éric Huyghe. June 2023, page 103

Sexual dysfunction after prostate cancer treatment

Changes in sexuality after prostate cancer treatment are very common, significantly impacting quality of life. Psychologically, body image, self-esteem and interpersonal relationships are...
 Ala Chebbi. December 2023, page 93

Living with… prostate cancer

 Roland Muntz. March 2024, page 66

Infectious endocarditis and cancers: results of the EURO-ENDO registry

 Bernard Cosyns, Gilbert Habib. October 2024, page 55

When and how should a stool blood test be prescribed?

 Bernard Denis, Lionel Tabard, Christelle Guillon, Julien L’hirondel, Callum G Fraser. March 2025, page 18

Zosteriform skin metastases

 Youssef Almheirat, Sara Bensalem, Houda Talbi, Nassiba Zarrouki, Siham Dikhaye, Nada Zizi. March 2025, page 59